Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Pharmacokinetics and efficacy of ranibizumab in exudative AMD

May 14, 2004

Prostanoid compound RUG-015 effectively reduces intraocular pressure

May 14, 2004

Novel somatostatin conjugate effective for treatment of choroidal neovascularization in vivo

May 14, 2004

Preclinical efficacy of prostaglandin analogues AL-12180 and AL-12182

May 13, 2004

Improvement of diabetes-induced retinal vascular abnormalities by AGIX-4207

May 13, 2004

Antibody against collagen IV cryptic epitope limits choroidal neovascularization in vivo

May 13, 2004

Visudyne launched in Japan

May 12, 2004

Promising results reported for AdPEDF.11 in choroidal neovascularization

May 12, 2004

Talaporfin reported to reduce choroidal leakage in ARMD

May 12, 2004

Dendrimer therapy effective against excessive post-eye surgery scarring

May 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...